Kobayashi Pharmaceutical Co. Ltd. said its normalized net income for the fiscal third quarter ended Dec. 31, 2014, came to ¥56.33 per share, a gain of 10.6% from ¥50.91 per share in the prior-year period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥4.59 billion, a gain of 10.0% from ¥4.17 billion in the year-earlier period.
The normalized profit margin increased to 11.9% from 11.1% in the year-earlier period.
Total revenue climbed on an annual basis to ¥38.63 billion from ¥37.48 billion, and total operating expenses grew on an annual basis to ¥31.63 billion from ¥31.04 billion.
Reported net income rose 21.5% year over year to ¥5.22 billion, or ¥64.08 per share, from ¥4.30 billion, or ¥52.46 per share.
As of Feb. 6, US$1 was equivalent to ¥119.01.
